Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
MaxiCalc: A tool for online dosimetric evaluation of source-tracking based treatment verification in HDR brachytherapy

Hanlon MD, Smith RL, Franich RD

(2022), PHYS MEDICA, 94, 58-64

DOI: 101016/jejmp202112008

Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in Australia

Ong WL, Evans M, Papa N, Millar J

(2022), CLIN TRANSL RAD ONCO, 37, 19-24

DOI: 101016/jctro202208009

Changing pattern of radiation therapy for bone metastases in an Australian population-based cohort of men with prostate cancer

Ong WL, Milne RL, Foroudi F, Millar JL

(2022), CLIN GENITOURIN CANC, 20(1), e7-15

DOI: 101016/jclgc202107007

Establishing metastatic prostate cancer quality indicators using a modified Delphi approach

Zheng J, Sampurno F, George DJ, Morgans AK, Nguyen H, Abrahm JL, Bjartell A, Davis ID, Fitch MI, Gillessen S, Kanesvaran R, Matthew A, Millar JL, O'Sullivan JM, Payne H, Pouliot F, Yates P, Evans SM

(2022), CLIN GENITOURIN CANC, 20(2), e151-7

DOI: 101016/jclgc202111018

Disparities in quality of life, social distress and employment outcomes in Australian cancer survivors

White VM, Lisy K, Ward A, Ristevski E, Clode M, Webber K, Emery J, Ijzerman MJ, Afshar N, Millar J, Gibbs P, Evans S, Jefford M

(2022), Support Care Cancer, 30(6), 5299-309

DOI: 101007/s00520-022-06914-w

Use of a PLA sleeve to remove electron enhancement in superficial X-ray therapy

Barbagallo C

(2022), Phys Eng Sci Med, 45(3), 1005-11

DOI: 101007/s13246-022-01163-x

Self-reported lack of energy or feeling depressed 12 months after treatment in men diagnosed with prostate cancer within a population-based registry

Bensley JG, Dhillon HM, Evans SM, Evans M, Bolton D, Davis ID, Dodds L, Frydenberg M, Kearns P, Lawrentschuk N, Murphy DG, Millar JL, Papa N

(2022), PSYCHO-ONCOLOGY, 31(3), 496-503

DOI: 101002/pon5833

Blood T-cell profiling in metastatic melanoma patients as a marker for response to immune checkpoint inhibitors combined with radiotherapy

Ratnayake G, Reinwald S, Edwards J, Wong N, Yu D, Ward R, Smith R, Haydon A, Au PM, van Zelm MC, Senthi S

(2022), Radiother Oncol, 173, 299-305

DOI: 101016/jradonc202206016

Application of an automated dose accumulation workflow in high-risk prostate cancer - validation and dose-volume analysis between planned and delivered dose

Ong A, Knight K, Panettieri V, Dimmock M, Tuan JKL, Tan HQ, Master Z, Wright C

(2022), Med Dosim, 47(1), 92-7

DOI: 101016/jmeddos202109004

Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer

Azad AA, Tran B, Davis ID, Parente P, Evans M, Wong S, Brown S, Evans S, Millar J, Murphy DG, Papa N

(2022), Intern Med J, 52(8), 1339-46

DOI: 101111/imj15288

1 2